-
Publication Date2021-06
Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson's Disease
Heeyoung An; Lee, Hyowon; Yang, Seulkee, et al
-
Publication Date2022-02-01
CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease in Vivo
Yoon, Hyung Ho; Ye, Sunghyeok; Lim, Sunhwa, et al
-
Publication Date2021-06
Differential Proximity of Perisynaptic Astrocytic Best1 at the Excitatory and Inhibitory Tripartite Synapses in APP/PS1 and MAOB-KO Mice Revealed by Lattice Structured Illumination Microscopy
Heeyoung An; Wuhyun Koh; SeungHee Kang, et al
-
Publication Date2021-10
KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson’s Disease
Nam, Min-Ho; Park, Jong-Hyun; Song, Hyo Jung, et al
-
Publication Date2021-07
Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis
Cho, Hyun-U; Sunpil Kim; Sim, Jeongeun, et al
-
Publication Date2021-04
The pathological role of astrocytic MAOB in parkinsonism revealed by genetic ablation and over-expression of MAOB
Heeyoung An; Heo, Jun Young; C. Justin Lee, et al